首頁 > 市場調查報告書 > 製藥

再生醫學細胞療法

市場調查報告書

商品編碼

1904895

幹細胞療法市場規模、佔有率和成長分析（治療方法、類型、來源、給藥途徑、技術、應用和地區分類）—2026-2033年產業預測

Stem Cell Therapy Market Size, Share, and Growth Analysis, By Therapy, By Type, By Source, By Route of Administration, By Technology, By Application, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月25日 | 出版商:

SkyQuest | 英文 197 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

全球幹細胞治療市場規模預計在 2024 年達到 3.6962 億美元，從 2025 年的 4.3874 億美元成長到 2033 年的 17.2907 億美元，在預測期（2026-2033 年）內複合年成長率為 18.7%。

全球幹細胞治療市場正經歷顯著擴張，這主要得益於慢性疾病發病率的上升以及幹細胞療法作為高效、以療效為導向的治療方法的廣泛應用。監管支持的加強和消費者對再生醫學日益成長的需求也推動了市場發展。利用間質幹細胞（MSCs）和誘導性多功能幹細胞（iPSCs）的細胞療法尤其引人注目，並已被應用於包括神經系統疾病、心臟病和肌肉骨骼疾病在內的多個治療領域。然而，市場成長仍面臨諸多挑戰，例如與研發、臨床試驗和監管核准相關的高昂前期成本，以及商業化方面的技術難題。

全球幹細胞治療市場按類型、治療方法、來源、給藥途徑、技術、應用、最終用戶和地區進行細分。按類型分類，幹細胞治療市場可分為全能幹細胞、多能幹細胞、多功能能幹細胞、單能幹細胞和其他類型。治療方法，異體幹細胞治療和自體幹細胞療法。依來源分類，幹細胞治療市場可分為成體幹細胞、胚胎幹細胞、間質幹細胞（MSCs）及誘導性多功能幹細胞（iPS）。依給藥途徑分類，幹細胞治療市場可分為靜脈注射、關節內注射、鞘內注射、皮內注射及其他途徑。依技術分類，幹細胞治療市場可分為細胞採集（骨髓採集、臍帶血採集、血球分離術）、細胞生產（治療性克隆、體外受精、細胞培養、分離）、冷凍保存和擴增/繼代培養。按應用領域分類，該市場可分為肌肉骨骼疾病、傷口/手術、發炎/自體免疫疾病、心血管疾病、神經系統疾病及其他。依最終用戶分類，市場可分為醫院、專科診所、學術和研究機構及其他。分析按地區分類：北美、歐洲、亞太、中東和非洲以及拉丁美洲。

全球幹細胞治療市場促進因素

全球幹細胞治療市場主要得益於政府機構的財政支持和有利的法規結構，從而為該領域的研究和開發創造了有利環境。這種支持促進了細胞研究的各項研究舉措和資金籌措投入。這主要是由於迫切需要針對包括自體免疫、神經系統疾病和心血管疾病在內的各種疾病的創新有效療法。對生物製造設施等基礎設施建設的投資進一步推動了幹細胞治療的發展，增強了推動這一充滿前景的醫學領域的能力和資源。

限制全球幹細胞治療市場的因素

全球幹細胞治療市場面臨許多挑戰，主要源自於使用源自人類胚胎的胚胎幹細胞所引發的倫理問題。這引發了與可能終止人類生命相關的深刻道德問題，使幹細胞研發格局變得複雜。此外，幹細胞治療的監管環境也存在差異，受到不同地區文化和社會價值觀的影響。這種不一致不僅阻礙了創新，也為研究人員和投資者帶來了不不確定性，最終限制了幹細胞療法在市場上的發展和商業化。

全球幹細胞療法市場趨勢

全球幹細胞治療市場正呈現出顯著的創新和先進治療方法研發趨勢，各公司都在積極尋求專業人才來推動研究、開發和應用。再生醫學領域的突破性進展加速了對具備基因工程、細胞生物學和臨床試驗管理等專業知識的人才的需求。這一趨勢反映了幹細胞研究領域投資的不斷成長，以及生物技術公司、學術機構和醫療服務提供者之間合作的日益密切。因此，在有望改變多種疾病治療模式的進步推動下，該市場預計將實現強勁成長。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2023-2025年營收年比比較

主要企業簡介

Smith & Nephew plc（United Kingdom）
Medipost Co. Ltd.（South Korea）
JCR Pharmaceuticals Co., Ltd.（Japan）
Takeda Pharmaceutical Company Limited（Japan）
Anterogen Co., Ltd.（South Korea）
Corestem, Inc.（South Korea）
Pharmicell Co., Ltd（South Korea）
NuVasive, Inc.（United States）
Holostem SRL（Italy）
Orthofix Medical Inc.（United States）
Stempeutics Research Pvt Ltd.（India）
Regrow Biosciences Pvt Ltd.（India）
Healios KK（Japan）
Mesoblast Ltd.（Australia）
BioRestorative Therapies, Inc.（United States）
Pluri Inc.（Israel）
BrainStorm Cell Inc（United States）
Ayrmid Limited（Gamida Cell）（United Kingdom）
Vertex Pharmaceuticals（ViaCyte, Inc.）（United States）
Kangstem Biotech Co., Ltd.（South Korea）

結論與建議

簡介目錄

Product Code: SQMIG35H2162

Global Stem Cell Therapy market size was valued at USD 369.62 Million in 2024 and is poised to grow from USD 438.74 Million in 2025 to USD 1729.07 Million by 2033, growing at a CAGR of 18.7% in the forecast period (2026-2033).

The global stem cell therapy market is experiencing notable expansion, propelled by the rising incidence of chronic diseases and the adoption of stem cell-based treatments as effective outcome-oriented solutions. This market benefits from increasing regulatory support and a growing consumer demand for regenerative medicine. Notably, cell therapies utilizing Mesenchymal Stem Cells (MSCs) and Induced Pluripotent Stem Cells (iPS) are becoming prominent, with applications emerging across various therapeutic fields such as neurology, cardiology, and musculoskeletal disorders. Nonetheless, significant challenges persist, including the high upfront costs associated with research, clinical trials, and regulatory approvals, alongside technical difficulties in commercialization, which collectively act as substantial barriers to market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Stem Cell Therapy market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Stem Cell Therapy Market Segments Analysis

The global stem cell therapy market is segmented into type, therapy, source, route of administration, technology, application, end user, and region. By type, the market is classified into Totipotent Stem Cells, Multipotent Stem Cells, Pluripotent Stem Cells, Unipotent Stem Cells, Others. Depending on therapy, it is divided into Allogeneic Stem Cell Therapy and Autologous Stem Cell Therapy. According to source, the market is categorized into Adult Stem Cells, Embryonic Stem Cells, Mesenchymal Stem Cells (MSCs), and Induced Pluripotent Stem Cells (iPS). Depending on route of administration, it is divided into Intravenous (IV) Infusion, Intraarticular Injection, Intrathecal Injection, Intradermal Injection, Others. By technology, the market is classified into Cell Acquisition (Bone Marrow Harvest, Umbilical Blood Cord, Apheresis), Cell Production (Therapeutic Cloning, In-vitro Fertilization, Cell Culture, Isolation), Cryopreservation, Expansion and Sub-Culture. According to application, the market is categorized into Musculoskeletal Disorders, Wounds & Surgeries, Inflammatory & Autoimmune Diseases, Cardiovascular Diseases, Neurological Disorders, and Others. By end user, the market is classified into Hospitals, Specialty Clinics, Academic & Research Institutes, and Others. Regionally, the market is analyzed across North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.

Driver of the Global Stem Cell Therapy Market

The Global Stem Cell Therapy market is significantly driven by financial support from governmental bodies and favorable regulatory frameworks, which create an encouraging environment for research and development in the field. This support has fostered heightened research initiatives and funding opportunities for cellular studies, largely due to the pressing demand for innovative and effective treatment solutions for a variety of conditions, including autoimmune, neurological, and cardiovascular diseases. Such investments in developing infrastructure, like biomanufacturing facilities, further bolster the growth of stem cell therapies, enhancing both the capabilities and resources available for advancing this promising area of medicine.

Restraints in the Global Stem Cell Therapy Market

The global stem cell therapy market faces significant challenges due to ethical concerns surrounding the use of embryonic stem cells, primarily derived from human embryos. This raises profound moral questions related to the potential termination of human life, which complicates the landscape of stem cell research and development. Additionally, the regulatory environment governing stem cell therapies is inconsistent across different regions, influenced by varying cultural and societal attitudes. Such disparities not only stymie innovation but also create uncertainty for researchers and investors, ultimately limiting the progress and commercialization of stem cell therapies in the marketplace.

Market Trends of the Global Stem Cell Therapy Market

The Global Stem Cell Therapy market is experiencing a significant trend towards innovation and the development of advanced therapeutics, prompting companies to seek specialized talent to drive research and application. As breakthroughs in regenerative medicine gain momentum, the demand for skilled professionals with expertise in genetic engineering, cellular biology, and clinical trial management is intensifying. This trend reflects the growing investment in stem cell research and the increasing collaboration between biotech firms, academic institutions, and healthcare providers. Consequently, the market is positioned for robust growth, fueled by advancements that promise to transform treatment paradigms across various medical conditions.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Landscape
Case Study Analysis
Patent Analysis

Global Stem Cell Therapy Market Size by Type & CAGR (2026-2033)

Market Overview
Totipotent Stem Cells
Multipotent Stem Cells
Pluripotent Stem Cells
Unipotent Stem Cells
Others

Global Stem Cell Therapy Market Size by Therapy & CAGR (2026-2033)

Market Overview
Allogeneic Stem Cell Therapy
Autologous Stem Cell Therapy

Global Stem Cell Therapy Market Size by Source & CAGR (2026-2033)

Market Overview
Adult Stem Cells
Embryonic Stem Cells
Mesenchymal Stem Cells (MSCs)
Induced Pluripotent Stem Cells (iPS)

Global Stem Cell Therapy Market Size by Route of Administration & CAGR (2026-2033)

Market Overview
Intravenous (IV) Infusion
Intraarticular Injection
Intrathecal Injection
Intradermal Injection
Others

Global Stem Cell Therapy Market Size by Technology & CAGR (2026-2033)

Market Overview
Cell Acquisition
- Bone Marrow Harvest
- Umbilical Blood Cord
- Apheresis
Cell Production
- Therapeutic Cloning
- In-vitro Fertilization
- Cell Culture
- Isolation
Cryopreservation
Expansion and Sub-Culture

Global Stem Cell Therapy Market Size by Application & CAGR (2026-2033)

Market Overview
Musculoskeletal Disorders
Wounds & Surgeries
Inflammatory & Autoimmune Diseases
Cardiovascular Diseases
Neurological Disorders
Others

Global Stem Cell Therapy Market Size by End User & CAGR (2026-2033)

Market Overview
Hospitals
Specialty Clinics
Academic & Research Institutes
Others

Global Stem Cell Therapy Market Size & CAGR (2026-2033)

North America (Type, Therapy, Source, Route of Administration, Technology, Application, End User)
- US
- Canada
Europe (Type, Therapy, Source, Route of Administration, Technology, Application, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Type, Therapy, Source, Route of Administration, Technology, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Type, Therapy, Source, Route of Administration, Technology, Application, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Type, Therapy, Source, Route of Administration, Technology, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Smith & Nephew plc (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medipost Co. Ltd. (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
JCR Pharmaceuticals Co., Ltd. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Takeda Pharmaceutical Company Limited (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Anterogen Co., Ltd. (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Corestem, Inc. (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pharmicell Co., Ltd (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
NuVasive, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Holostem SRL (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Orthofix Medical Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stempeutics Research Pvt Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Regrow Biosciences Pvt Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Healios KK (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mesoblast Ltd. (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioRestorative Therapies, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pluri Inc. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BrainStorm Cell Inc (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ayrmid Limited (Gamida Cell) (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Vertex Pharmaceuticals (ViaCyte, Inc.) (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Kangstem Biotech Co., Ltd. (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments